195 related articles for article (PubMed ID: 15858076)
21. Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumption.
Bloom AJ; Murphy SE; Martinez M; von Weymarn LB; Bierut LJ; Goate A
Pharmacogenet Genomics; 2013 Feb; 23(2):62-8. PubMed ID: 23211429
[TBL] [Abstract][Full Text] [Related]
22. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.
Zhou J; Shephard EA
Mutat Res; 2006 Jun; 612(3):165-171. PubMed ID: 16481213
[TBL] [Abstract][Full Text] [Related]
23. Non-synonymous genetic variants of flavin-containing monooxygenase 3 (FMO3) in cynomolgus macaques.
Uno Y; Shimizu M; Yoda H; Origuchi Y; Yamazaki H
Drug Metab Pharmacokinet; 2019 Feb; 34(1):104-107. PubMed ID: 30420260
[TBL] [Abstract][Full Text] [Related]
24. Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.
Krueger SK; Siddens LK; Henderson MC; Andreasen EA; Tanguay RL; Pereira CB; Cabacungan ET; Hines RN; Ardlie KG; Williams DE
Pharmacogenet Genomics; 2005 Apr; 15(4):245-56. PubMed ID: 15864117
[TBL] [Abstract][Full Text] [Related]
25. Molecular cloning, sequencing, and expression in Escherichia coli of mouse flavin-containing monooxygenase 3 (FMO3): comparison with the human isoform.
Falls JG; Cherrington NJ; Clements KM; Philpot RM; Levi PE; Rose RL; Hodgson E
Arch Biochem Biophys; 1997 Nov; 347(1):9-18. PubMed ID: 9344459
[TBL] [Abstract][Full Text] [Related]
26. Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
Shimizu M; Kobayashi Y; Hayashi S; Aoki Y; Yamazaki H
Mol Genet Metab; 2012 Nov; 107(3):330-4. PubMed ID: 22819296
[TBL] [Abstract][Full Text] [Related]
27. Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities.
Yamazaki H; Shimizu M
Biochem Pharmacol; 2013 Jun; 85(11):1588-93. PubMed ID: 23567996
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.
Aklillu E; Carrillo JA; Makonnen E; Hellman K; Pitarque M; Bertilsson L; Ingelman-Sundberg M
Mol Pharmacol; 2003 Sep; 64(3):659-69. PubMed ID: 12920202
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.
Yeung CK; Adman ET; Rettie AE
Arch Biochem Biophys; 2007 Aug; 464(2):251-9. PubMed ID: 17531949
[TBL] [Abstract][Full Text] [Related]
30. Analysis of flavin-containing monooxygenase 3 genotype data in populations administered the anti-schizophrenia agent olanzapine.
Cashman JR; Zhang J; Nelson MR; Braun A
Drug Metab Lett; 2008 Apr; 2(2):100-14. PubMed ID: 19356079
[TBL] [Abstract][Full Text] [Related]
31. Missense and nonsense mutations of the flavin-containing monooxygenase 3 gene in a Japanese cohort.
Shimizu M; Tomioka S; Murayama N; Yamazaki H
Drug Metab Pharmacokinet; 2007 Feb; 22(1):61-4. PubMed ID: 17329912
[TBL] [Abstract][Full Text] [Related]
32. Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.
Motika MS; Zhang J; Zheng X; Riedler K; Cashman JR
Mol Genet Metab; 2009 Jun; 97(2):128-35. PubMed ID: 19321370
[TBL] [Abstract][Full Text] [Related]
33. Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.
Shimizu M; Allerston CK; Shephard EA; Yamazaki H; Phillips IR
Br J Clin Pharmacol; 2014 May; 77(5):839-51. PubMed ID: 24028545
[TBL] [Abstract][Full Text] [Related]
34. Genetic variants of flavin-containing monooxygenase 3 (FMO3) derived from Japanese subjects with the trimethylaminuria phenotype and whole-genome sequence data from a large Japanese database.
Shimizu M; Yoda H; Nakakuki K; Saso A; Saito I; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
Drug Metab Pharmacokinet; 2019 Oct; 34(5):334-339. PubMed ID: 31401033
[TBL] [Abstract][Full Text] [Related]
35. Investigation of structure and function of a catalytically efficient variant of the human flavin-containing monooxygenase form 3.
Borbás T; Zhang J; Cerny MA; Likó I; Cashman JR
Drug Metab Dispos; 2006 Dec; 34(12):1995-2002. PubMed ID: 16985102
[TBL] [Abstract][Full Text] [Related]
36. Alternative processing events in human FMO genes.
Lattard V; Zhang J; Cashman JR
Mol Pharmacol; 2004 Jun; 65(6):1517-25. PubMed ID: 15155844
[TBL] [Abstract][Full Text] [Related]
37. Novel variants and haplotypes of human
Shimizu M; Yoda H; Igarashi N; Makino M; Tokuyama E; Yamazaki H
Xenobiotica; 2019 Oct; 49(10):1244-1250. PubMed ID: 30351217
[TBL] [Abstract][Full Text] [Related]
38. Novel variants in outer protein surface of flavin-containing monooxygenase 3 found in an Argentinian case with impaired capacity for trimethylamine N-oxygenation.
Dionisio L; Shimizu M; Stupniki S; Oyama S; Aztiria E; Alda M; Yamazaki H; Spitzmaul G
Drug Metab Pharmacokinet; 2020 Aug; 35(4):383-388. PubMed ID: 32653296
[TBL] [Abstract][Full Text] [Related]
39. The promoter region of the MDR1 gene is largely invariant, but different single nucleotide polymorphism haplotypes affect MDR1 promoter activity differently in different cell lines.
Wang B; Ngoi S; Wang J; Chong SS; Lee CG
Mol Pharmacol; 2006 Jul; 70(1):267-76. PubMed ID: 16608921
[TBL] [Abstract][Full Text] [Related]
40. Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain.
Teitelbaum AM; Murphy SE; Akk G; Baker TB; Germann A; von Weymarn LB; Bierut LJ; Goate A; Kharasch ED; Bloom AJ
Pharmacogenomics J; 2018 Jan; 18(1):136-143. PubMed ID: 28290528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
